The US Food and Drug Administration has issued Emergency Use Authorization (EUA) to Abbott Laboratories Inc. for a COVID-19 test, the company announced 18 March.
Abbott said it will ship 150,000 Abbott RealTime SARS-CoV-2 EUA tests to existing customers in the US and ramp up...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?